AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1251319 — intervention group
Group type: EXPERIMENTAL
Intervention: Sepsis group (both groups)
Number of subjects: 30
Study 30216239 — intervention group
Group type: EXPERIMENTAL
Intervention: RMSIT
Number of subjects: 36
Study 30216239 — intervention group
Group type: EXPERIMENTAL
Intervention: RMET
Number of subjects: 36
Study 30216239 — intervention group
Group type: COMPARATOR
Intervention: PLAT
Number of subjects: 36
Study 30385541 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional physical therapy plus TENMS
Number of subjects: 68
Study 30385541 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy alone (control group)
Number of subjects: 68
Study 30385541 — intervention group
Group type: EXPERIMENTAL
Intervention: TENMS
Number of subjects: 68
Study 30385541 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 68
Study 26136525 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarettes
Number of subjects: 123399
Study 26136525 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigars
Number of subjects: 123399
Study 26136525 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing Tobacco
Number of subjects: 123399
Study 26136525 — intervention group
Group type: EXPERIMENTAL
Intervention: Snuff
Number of subjects: 123399
Study 24565934 — intervention group
Group type: EXPERIMENTAL
Intervention: GYNEFFIK(®) electro-stimulation sessions
Number of subjects: 95
Study 24565934 — intervention group
Group type: COMPARATOR
Intervention: Usual care (no electro-stimulation)
Number of subjects: 95
Study 22160629 — intervention group
Group type: EXPERIMENTAL
Intervention: Center-based exercise and lymphedema education intervention
Number of subjects: 104
Study 22160629 — intervention group
Group type: COMPARATOR
Intervention: Patient education
Number of subjects: 104
Study 19077911 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mmoL/kg gadobenate dimeglumine (Gd-BOPTA)
Number of subjects: 40
Study 19077911 — intervention group
Group type: COMPARATOR
Intervention: 0.2 mmoL/kg gadopentetate dimeglumine (Gd-DTPA)
Number of subjects: 40
Study 17760868 — intervention group
Group type: EXPERIMENTAL
Intervention: 850 degrees C/0.5 hr
Number of subjects: 60
Study 17760868 — intervention group
Group type: EXPERIMENTAL
Intervention: 850 degrees C/1 hr
Number of subjects: 60
Study 17760868 — intervention group
Group type: EXPERIMENTAL
Intervention: 850 degrees C/3 hr
Number of subjects: 60
Study 17760868 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 degrees C/6 hr
Number of subjects: 60
Study 17760868 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 degrees C/6 hr
Number of subjects: 60
Study 17760868 — intervention group
Group type: EXPERIMENTAL
Intervention: 850 degrees C/6 hr
Number of subjects: 60
Study 15376797 — intervention group
Group type: EXPERIMENTAL
Intervention: Famous faces rated as 'good'
Number of subjects: 0
Study 15376797 — intervention group
Group type: EXPERIMENTAL
Intervention: Famous faces rated as 'evil'
Number of subjects: 0
Study 15376797 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who liked the famous person
Number of subjects: 0
Study 15376797 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who disliked the famous person
Number of subjects: 0
Study 11257395 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant active specific immunotherapy
Number of subjects: 0
Study 9637643 — intervention group
Group type: EXPERIMENTAL
Intervention: Local-anesthetic-only group (5 ml 0.25% bupivacaine without catheter manipulation)
Number of subjects: 78
Study 9637643 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter-manipulation group (5 ml 0.25% bupivacaine after withdrawing the catheter 1 cm)
Number of subjects: 78
Study 9160564 — intervention group
Group type: EXPERIMENTAL
Intervention: L‐365,260 (30 mg four times daily for six weeks)
Number of subjects: 38
Study 9160564 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for six weeks)
Number of subjects: 38
Study 2686478 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol 5 mg and Lorazepam 4 mg
Number of subjects: 0
Study 2686478 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiothixene 5 mg and Lorazepam 4 mg
Number of subjects: 0
Study 2686478 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol 5 mg and Phenobarbital sodium 130 mg
Number of subjects: 0
Study 5114822 — intervention group
Group type: EXPERIMENTAL
Intervention: Marihuana smoke administration
Number of subjects: 0
Study 5114822 — intervention group
Group type: COMPARATOR
Intervention: Placebo smoke administration
Number of subjects: 0
Study 31701693 — intervention group
Group type: EXPERIMENTAL
Intervention: South Asian men with prediabetes and overweight or obesity
Number of subjects: 20
Study 29197080 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 ml boluses of bupivacaine 0.0625% + fentanyl 2 μg.ml‐1 at a 40 min interval
Number of subjects: 40
Study 29037230 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component intervention focusing on knowledge of health effects of SHS, attitudes towards SHS exposure, right to smoke-free living, and women empowerment against smoking for 6 months.
Number of subjects: 750
Study 29037230 — intervention group
Group type: COMPARATOR
Intervention: Control group received no intervention.
Number of subjects: 750
Study 26226215 — intervention group
Group type: EXPERIMENTAL
Intervention: High reversibility (HR) asthma
Number of subjects: 0
Study 26226215 — intervention group
Group type: COMPARATOR
Intervention: Low reversibility (LR) asthma
Number of subjects: 0
Study 24220504 — intervention group
Group type: EXPERIMENTAL
Intervention: Golden plaster administered externally for 2 weeks
Number of subjects: 320
Study 24220504 — intervention group
Group type: COMPARATOR
Intervention: Placebo plaster administered externally for 2 weeks
Number of subjects: 320
Study 21911741 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (20,000 IU vitamin D(3) twice weekly for 6 months)
Number of subjects: 108
Study 21911741 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical-looking capsules)
Number of subjects: 108
Study 18368834 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron as lingual tablets
Number of subjects: 4
Study 18368834 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron as syrup
Number of subjects: 4
Study 18368834 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron intravenously injected during induction to anesthesia
Number of subjects: 4
Study 18368834 — intervention group
Group type: COMPARATOR
Intervention: No antiemetics (control group)
Number of subjects: 4
Study 16809741 — intervention group
Group type: EXPERIMENTAL
Intervention: HRQL assessment in surgical oncology trials
Number of subjects: 33
Study 16809741 — intervention group
Group type: EXPERIMENTAL
Intervention: HRQL assessment in surgical oncology trials with robust design
Number of subjects: 33
Study 11820367 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal immunization with glucosyltransferase-enriched preparation (E-GTF)
Number of subjects: 21
Study 11820367 — intervention group
Group type: COMPARATOR
Intervention: Tonsillar immunization with glucosyltransferase-enriched preparation (E-GTF)
Number of subjects: 21
Study 10638341 — intervention group
Group type: EXPERIMENTAL
Intervention: External nasal dilator strip (ENDS)
Number of subjects: 9
Study 8674466 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol (HAL) administered orally at three fixed doses: 6 mg per day, 10 mg per day, and 15 mg per day for 2 weeks.
Number of subjects: 15
Study 2105256 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral-tube feeding as the sole nutritional support (n = 16)
Number of subjects: 35
Study 2105256 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric, isonitrogenous, low‐sodium standard oral diet (n = 19)
Number of subjects: 35
Study 7408673 — intervention group
Group type: EXPERIMENTAL
Intervention: Irrigation treatment with Capmul 8210
Number of subjects: 11
Study 28916955 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-port laparoscopic surgery (SPLS)
Number of subjects: 194
Study 28916955 — intervention group
Group type: COMPARATOR
Intervention: Multiport laparoscopic surgery (MPLS)
Number of subjects: 194
Study 28802448 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-color design
Number of subjects: 0
Study 28802448 — intervention group
Group type: EXPERIMENTAL
Intervention: Grayscale design
Number of subjects: 0
Study 28802448 — intervention group
Group type: EXPERIMENTAL
Intervention: Map background
Number of subjects: 0
Study 28802448 — intervention group
Group type: COMPARATOR
Intervention: Radar background
Number of subjects: 0
Study 25616294 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose amino acids (3.0 g/kg per day, increasing by 0.5-1.0 g/kg daily, max 4.0 g/kg per day)
Number of subjects: 86
Study 25616294 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-dose amino acids (2.0 g/kg per day, increasing by 1.0 g/kg daily, max 3.7 g/kg per day)
Number of subjects: 86
Study 25616294 — intervention group
Group type: COMPARATOR
Intervention: Low-dose amino acids (1.0 g/kg per day, increasing by 1.0 g/kg daily, max 3.5 g/kg per day)
Number of subjects: 86
Study 25616294 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose amino acids (3.0 g/kg per day)
Number of subjects: 86
Study 25616294 — intervention group
Group type: COMPARATOR
Intervention: Low-dose amino acids (1.0 g/kg per day)
Number of subjects: 86
Study 23020146 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenting program plus a reading intervention (n = 88)
Number of subjects: 174
Study 23020146 — intervention group
Group type: COMPARATOR
Intervention: Nonintervention condition (n = 86)
Number of subjects: 174
Study 20374582 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient microwave endometrial ablation in the postmenstrual phase
Number of subjects: 197
Study 20374582 — intervention group
Group type: COMPARATOR
Intervention: Day surgery microwave endometrial ablation after standard drug-based endometrial preparation
Number of subjects: 197
Study 20374582 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 197
Study 18414765 — intervention group
Group type: EXPERIMENTAL
Intervention: Monarc transobturator sling
Number of subjects: 155
Study 18414765 — intervention group
Group type: COMPARATOR
Intervention: Tension-free vaginal tape
Number of subjects: 155
Study 16172148 — intervention group
Group type: EXPERIMENTAL
Intervention: Single embryo transfer (SET)
Number of subjects: 0
Study 16172148 — intervention group
Group type: COMPARATOR
Intervention: Double embryo transfer (DET)
Number of subjects: 0
Study 14582612 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonlinear coupling during late TILT phase in TILT-positive group
Number of subjects: 21
Study 14582612 — intervention group
Group type: COMPARATOR
Intervention: Nonlinear coupling during late TILT phase in TILT-negative group
Number of subjects: 21
Study 10712322 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest radiographic screening
Number of subjects: 3
Study 10712322 — intervention group
Group type: EXPERIMENTAL
Intervention: Tuberculin skin testing
Number of subjects: 3
Study 10712322 — intervention group
Group type: COMPARATOR
Intervention: Mass tuberculin skin testing
Number of subjects: 3
Study 9403421 — intervention group
Group type: EXPERIMENTAL
Intervention: Ottawa Knee Rule implementation
Number of subjects: 3907
Study 9403421 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Ottawa Knee Rule)
Number of subjects: 3907
Study 8218757 — intervention group
Group type: EXPERIMENTAL
Intervention: Telenzepine (3 mg p.o.)
Number of subjects: 10
Study 8218757 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 3304794 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythrocyte sedimentation rate (ESR)
Number of subjects: 159
Study 3304794 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in ESR
Number of subjects: 159
Study 28868610 — intervention group
Group type: EXPERIMENTAL
Intervention: Cone-beam computed tomography (CBCT) imaging system (GALILEOS, Sirona Dental Systems, Bensheim, Germany) at 15‐30 mA and 98 kV
Number of subjects: 200
Study 27102223 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra and extra circumoral exercise (25 min a day, six times per week for 4 weeks)
Number of subjects: 41
Study 27102223 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 41
Study 24344670 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinoa flakes (QF)
Number of subjects: 35
Study 24344670 — intervention group
Group type: COMPARATOR
Intervention: Corn flakes (CF)
Number of subjects: 35
Study 22941315 — intervention group
Group type: EXPERIMENTAL
Intervention: Head eccentricity during touch presentation and response
Number of subjects: 0
Study 22941315 — intervention group
Group type: EXPERIMENTAL
Intervention: Head returned to center before reporting
Number of subjects: 0
Study 22941315 — intervention group
Group type: EXPERIMENTAL
Intervention: Gaze-centered reference frame
Number of subjects: 0
Study 22941315 — intervention group
Group type: EXPERIMENTAL
Intervention: Body-centered reference frame
Number of subjects: 0
Study 19860567 — intervention group
Group type: EXPERIMENTAL
Intervention: SCTG with Nd:YAG laser (1 W, 10 Hz, 100 mj, 60 s, 1064 nm)
Number of subjects: 17
Study 19860567 — intervention group
Group type: COMPARATOR
Intervention: SCTG without Nd:YAG laser (control group)
Number of subjects: 17
Study 18640464 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole 400 mg
Number of subjects: 36
Study 18640464 — intervention group
Group type: EXPERIMENTAL
Intervention: DIO-902 200 mg
Number of subjects: 36
Study 18640464 — intervention group
Group type: EXPERIMENTAL
Intervention: DIO-902 400 mg
Number of subjects: 36
Study 18640464 — intervention group
Group type: EXPERIMENTAL
Intervention: DIO-902 600 mg
Number of subjects: 36
Study 18640464 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 18640464 — intervention group
Group type: EXPERIMENTAL
Intervention: DIO-902 (all doses)
Number of subjects: 36
Study 16155269 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified milk with 1000 microg crystalline cobalamin
Number of subjects: 112
Study 16155269 — intervention group
Group type: EXPERIMENTAL
Intervention: Cobalamin capsule with 1000 microg crystalline cobalamin
Number of subjects: 112
Study 16155269 — intervention group
Group type: COMPARATOR
Intervention: Placebo milk
Number of subjects: 112
Study 16155269 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsule
Number of subjects: 112
Study 12537676 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilocarpine 1% with Clonidine 0.06%
Number of subjects: 54
Study 12537676 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilocarpine 1% with Clonidine 0.125%
Number of subjects: 54
Study 12537676 — intervention group
Group type: COMPARATOR
Intervention: Timolol 0.25%
Number of subjects: 54
Study 9825270 — intervention group
Group type: EXPERIMENTAL
Intervention: SPA-S-565 (150 mg)
Number of subjects: 6
Study 9825270 — intervention group
Group type: COMPARATOR
Intervention: Rifampicin (150 mg)
Number of subjects: 6
Study 8131705 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen 375 mg, taken orally twice a day
Number of subjects: 28
Study 8131705 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 8131705 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen and Placebo (both groups)
Number of subjects: 28
Study 2529873 — intervention group
Group type: EXPERIMENTAL
Intervention: sulbactam/ampicillin
Number of subjects: 40
Study 2529873 — intervention group
Group type: COMPARATOR
Intervention: cefoxitin
Number of subjects: 40
Study 1105277 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% tetracaine
Number of subjects: 0
Study 1105277 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7452705 — intervention group
Group type: EXPERIMENTAL
Intervention: Keller Plan
Number of subjects: 196
Study 7452705 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 196
Study 7452705 — intervention group
Group type: COMPARATOR
Intervention: All other disciplines (Control and Keller Plan)
Number of subjects: 196
Study 31776364 — intervention group
Group type: EXPERIMENTAL
Intervention: Navigation
Number of subjects: 37
Study 31776364 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopy
Number of subjects: 37
Study 28087066 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastrografin
Number of subjects: 242
Study 28087066 — intervention group
Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 242
Study 26881508 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated radiotherapy (6 fractions per week, 66Gy/33#/5½ weeks)
Number of subjects: 133
Study 26881508 — intervention group
Group type: COMPARATOR
Intervention: Concurrent chemoradiation (CCRT) (5 fractions per week, 66Gy/33#/6½ weeks, with intravenous cisplatin 30 mg/m(2) weekly)
Number of subjects: 133
Study 26881508 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated radiotherapy
Number of subjects: 133
Study 26881508 — intervention group
Group type: COMPARATOR
Intervention: CCRT
Number of subjects: 133
Study 26881508 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 133
Study 24075779 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-agent trastuzumab or lapatinib
Number of subjects: 19
Study 22134468 — intervention group
Group type: EXPERIMENTAL
Intervention: PR‐STENT
Number of subjects: 18
Study 22134468 — intervention group
Group type: COMPARATOR
Intervention: NO‐STENT
Number of subjects: 18
Study 19101266 — intervention group
Group type: EXPERIMENTAL
Intervention: Left ventricular assisted technique (LVA)
Number of subjects: 73
Study 19101266 — intervention group
Group type: COMPARATOR
Intervention: Minimal extracorporeal circulation (MECC)
Number of subjects: 73
Study 17496418 — intervention group
Group type: EXPERIMENTAL
Intervention: Riopan Gel (800 mg magaldrate)
Number of subjects: 24
Study 17496418 — intervention group
Group type: EXPERIMENTAL
Intervention: Rennie (680 mg calcium carbonate and 80 mg magnesium carbonate)
Number of subjects: 24
Study 17496418 — intervention group
Group type: COMPARATOR
Intervention: Placebo (no drug)
Number of subjects: 24
Study 15374707 — intervention group
Group type: EXPERIMENTAL
Intervention: 17beta‐estradiol (2 mg) + norethisterone acetate (1 mg; E(2)‐NETA)
Number of subjects: 28
Study 15374707 — intervention group
Group type: EXPERIMENTAL
Intervention: raloxifene hCL (60 mg)
Number of subjects: 28
Study 12135137 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency catheter ablation (RF‐CA)
Number of subjects: 63
Study 12135137 — intervention group
Group type: COMPARATOR
Intervention: Control group (electrophysiologic study)
Number of subjects: 63
Study 9825188 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg moexipril hydrochloride (single oral dose)
Number of subjects: 0
Study 9825188 — intervention group
Group type: COMPARATOR
Intervention: Combined sequential hormone replacement therapy (HRT) for 25 days
Number of subjects: 0
Study 7907130 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel (200 to 420 mg/m2) administered as a 24‐hour intravenous infusion
Number of subjects: 30
Study 2576423 — intervention group
Group type: COMPARATOR
Intervention: Abrupt Withdrawal (AW) group (n=15) received placebo for 10 nights
Number of subjects: 36
Study 2576423 — intervention group
Group type: COMPARATOR
Intervention: Gradual Withdrawal (GW) group (n=16) received temazepam 5 mg for the first 4 nights, 2 mg for the next 4 nights, and placebo for the last 2 nights
Number of subjects: 36
Study 2576423 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline period for both groups (AW and GW)
Number of subjects: 36
Study 1089359 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 54
Study 1089359 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 30971217 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 320
Study 30971217 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 320
Study 30971217 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 320
Study 30971217 — intervention group
Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 320
Study 28374097 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional testing with LightCycler®SeptiFast during intervention period (IP)
Number of subjects: 1416
Study 28374097 — intervention group
Group type: COMPARATOR
Intervention: Standard diagnostic workup during control period (CP)
Number of subjects: 1416
Study 26374430 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent exercise training programme (supervised progressive resistance exercise training, balance-training, and walking for 5-7 consecutive days, 20 min sessions twice a day)
Number of subjects: 35
Study 26374430 — intervention group
Group type: COMPARATOR
Intervention: Conventional care (control group)
Number of subjects: 35
Study 23703041 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical music therapy (15-minute sessions, twice a day for three consecutive days)
Number of subjects: 12
Study 21233083 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA 250 mg/day
Number of subjects: 60
Study 21233083 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA 500 mg/day
Number of subjects: 60
Study 21233083 — intervention group
Group type: COMPARATOR
Intervention: DHA 250 mg/day and DHA 500 mg/day
Number of subjects: 60
Study 18069063 — intervention group
Group type: EXPERIMENTAL
Intervention: Live high-train low simulated altitude (ALT)
Number of subjects: 9
Study 18069063 — intervention group
Group type: COMPARATOR
Intervention: Matched control group (CON)
Number of subjects: 9
Study 17535990 — intervention group
Group type: COMPARATOR
Intervention: No intervention (baseline measurements before trial supplements)
Number of subjects: 381
Study 15161067 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal vaccination with CRM197 alone
Number of subjects: 0
Study 15161067 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal vaccination with CRM197 formulated with chitosan
Number of subjects: 0
Study 15161067 — intervention group
Group type: COMPARATOR
Intervention: Parenteral immunization with conventional diphtheria toxoid vaccine
Number of subjects: 0
Study 11963647 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg ambroxol hydrochloride lozenges
Number of subjects: 218
Study 11963647 — intervention group
Group type: COMPARATOR
Intervention: Placebo lozenges
Number of subjects: 218
Study 9814450 — intervention group
Group type: EXPERIMENTAL
Intervention: Early referral to an endocrinologist
Number of subjects: 70